 |
PDBsum entry 4y72
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
292 a.a.
|
 |
|
|
|
|
|
|
|
264 a.a.
|
 |
|
|
|
|
|
|
|
74 a.a.
|
 |
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase
|
 |
|
Title:
|
 |
Human cdk1/cyclinb1/cks2 with inhibitor
|
|
Structure:
|
 |
Cyclin-dependent kinase 1. Chain: a. Synonym: cdk1,cell division control protein 2 homolog,cell division protein kinase 1,p34 protein kinase. Engineered: yes. G2/mitotic-specific cyclin-b1. Chain: b. Engineered: yes. Cyclin-dependent kinases regulatory subunit 2.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: cdk1, cdc2, cdc28a, cdkn1, p34cdc2. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108. Expression_system_cell_line: sf9. Gene: ccnb1, ccnb. Expressed in: escherichia coli bl21(de3).
|
|
Resolution:
|
 |
|
2.30Å
|
R-factor:
|
0.190
|
R-free:
|
0.252
|
|
|
Authors:
|
 |
N.R.Brown,S.Korolchuk,M.P.Martin,W.Stanley,R.Moukhametzianov, M.E.M.Noble,J.A.Endicott
|
|
Key ref:
|
 |
N.R.Brown
et al.
(2015).
CDK1 structures reveal conserved and unique features of the essential cell cycle CDK.
Nat Commun,
6,
6769.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
13-Feb-15
|
Release date:
|
12-Aug-15
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P06493
(CDK1_HUMAN) -
Cyclin-dependent kinase 1 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
297 a.a.
292 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class 2:
|
 |
Chain A:
E.C.2.7.11.22
- cyclin-dependent kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
|
|
2.
|
L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
|
|
 |
 |
 |
 |
 |
L-seryl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
L-threonyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
Chain A:
E.C.2.7.11.23
- [RNA-polymerase]-subunit kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
[DNA-directed RNA polymerase] + ATP = phospho-[DNA-directed RNA polymerase] + ADP + H+
|
 |
 |
 |
 |
 |
[DNA-directed RNA polymerase]
|
+
|
ATP
|
=
|
phospho-[DNA-directed RNA polymerase]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Nat Commun
6:6769
(2015)
|
|
PubMed id:
|
|
|
|
|
| |
|
CDK1 structures reveal conserved and unique features of the essential cell cycle CDK.
|
|
N.R.Brown,
S.Korolchuk,
M.P.Martin,
W.A.Stanley,
R.Moukhametzianov,
M.E.Noble,
J.A.Endicott.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
CDK1 is the only essential cell cycle CDK in human cells and is required for
successful completion of M-phase. It is the founding member of the CDK family
and is conserved across all eukaryotes. Here we report the crystal structures of
complexes of CDK1-Cks1 and CDK1-cyclin B-Cks2. These structures confirm the
conserved nature of the inactive monomeric CDK fold and its ability to be
remodelled by cyclin binding. Relative to CDK2-cyclin A, CDK1-cyclin B is less
thermally stable, has a smaller interfacial surface, is more susceptible to
activation segment dephosphorylation and shows differences in the substrate
sequence features that determine activity. Both CDK1 and CDK2 are potential
cancer targets for which selective compounds are required. We also describe the
first structure of CDK1 bound to a potent ATP-competitive inhibitor and identify
aspects of CDK1 structure and plasticity that might be exploited to develop
CDK1-selective inhibitors.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
| |